These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30669716)

  • 1. [A new simple scoring system to determine the timing and efficacy of entecavir therapy in hepatitis B-related acute-on-chronic liver failure].
    Li XY; Lei RX
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(4):291-294. PubMed ID: 30669716
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of tenofovir alafenamide and entecavir for hepatitis B virus
    Peng W; Gu H; Jiang C; Liu J; Zhang J; Fu L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):194-201. PubMed ID: 35545409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenofovir Versus Entecavir for the Treatment of Acute-on-Chronic Liver Failure due to Reactivation of Chronic Hepatitis B With Genotypes B and C.
    Wan YM; Li YH; Xu ZY; Wu HM; Xu Y; Wu XN; Yang JH
    J Clin Gastroenterol; 2019 Apr; 53(4):e171-e177. PubMed ID: 29659382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [To investigate the opportunity of entecavir treatment for HBeAg-negative acute-on-chronic liver].
    Mai L; Yan Y; Zhang SQ; Ke WM; Cao H
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Aug; 27(4):286-8. PubMed ID: 24579477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lamivudine improves short-term outcome in hepatitis B virus-related acute-on-chronic liver failure patients with a high model for end-stage liver disease score.
    Li X; Gao F; Liu H; Zhang H; Liu Y; Ye X; Geng M; Sun L; Wang R; Li Y; Jiang Y; Wang X; Zhou G; Yang Z; Li A; Zeng H; Wang X
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):1-9. PubMed ID: 27749778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What MELD score mandates use of entecavir for ACLF-HBV HBeAg-negative patients?
    Yan Y; Mai L; Zheng YB; Zhang SQ; Xu WX; Gao ZL; Ke WM
    World J Gastroenterol; 2012 Sep; 18(33):4604-9. PubMed ID: 22969236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Lamivudine Versus Entecavir for Treating Chronic Hepatitis B Virus-related Acute Exacerbation and Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis.
    Huang KW; Tam KW; Luo JC; Kuan YC
    J Clin Gastroenterol; 2017 Jul; 51(6):539-547. PubMed ID: 28067752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype Matters in Patients with Acute-on-chronic Liver Failure Due to Reactivation of Chronic Hepatitis B.
    Wan YM; Li YH; Xu ZY; Wu HM; Wu XN; Xu Y
    Clin Transl Gastroenterol; 2018 Nov; 9(11):202. PubMed ID: 30416197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine.
    Bowden S; Locarnini S; Chang TT; Chao YC; Han KH; Gish RG; de Man RA; Yu M; Llamoso C; Tang H
    World J Gastroenterol; 2015 Apr; 21(15):4644-51. PubMed ID: 25914474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Risk of Acute Kidney Injury in Hepatitis B Virus-Related Acute on Chronic Liver Failure with Tenofovir Treatment.
    Zhang K; Lin S; Wang M; Huang J; Zhu Y
    Biomed Res Int; 2020; 2020():5728359. PubMed ID: 32596332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation.
    Chen CH; Lin CL; Hu TH; Hung CH; Tseng PL; Wang JH; Chang JY; Lu SN; Chien RN; Lee CM
    J Hepatol; 2014 Jun; 60(6):1127-34. PubMed ID: 24583247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is HBV viral load at admission associated with development of acute-on-chronic liver failure in patients with acute decompensation of chronic hepatitis B related cirrhosis?
    Lei JH; Peng F; Chen Z; Xiao XQ
    BMC Infect Dis; 2019 Apr; 19(1):363. PubMed ID: 31039732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Study of Treatment Outcome with Tenofovir Alafenamide and Entecavir in Patients with HBV Related Acute on Chronic Liver Failure.
    Somon MAU; Shwapnil MAM; Debnath CR; Noor-E-Alam SM; Tarafdar AJ; Ahmad MF; Ashrafujjaman M; Jhily KRA; Ashiq MS; Hasan MZ
    Mymensingh Med J; 2024 Jul; 33(3):696-705. PubMed ID: 38944709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entecavir treatment prevents disease progression in hepatitis B virus-related acute-on-chronic liver failure: establishment of a novel logistical regression model.
    Ma K; Guo W; Han M; Chen G; Chen T; Wu Z; Yang D; Huang J; Huang Y; Zhao X; Tian D; Song J; Qi J; Ning Q
    Hepatol Int; 2012 Oct; 6(4):735-43. PubMed ID: 26201523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological outcome for chronic hepatitis B patients treated with entecavir vs lamivudine-based therapy.
    Wang JL; Du XF; Chen SL; Yu YQ; Wang J; Hu XQ; Shao LY; Chen JZ; Weng XH; Zhang WH
    World J Gastroenterol; 2015 Aug; 21(32):9598-606. PubMed ID: 26327767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of telbivudine compared with entecavir in hepatitis B virus-related cirrhosis: 2 year follow-up data.
    Kim HR; Yim HJ; Kang S; Suh SJ; Kim SY; Hyun JJ; Koo JS; Kim JH; Seo YS; Yeon JE; Lee SW; Byun KS; Um SH
    Liver Int; 2015 Mar; 35(3):860-9. PubMed ID: 24905912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Discussion on the meaning of MELD score in the opportunity of the entecavir treatment of HBeAg-negative acute-on-chronic liver failure].
    Yan Y; Mai L; Zhu JY; Zhang Y; Ke WM
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Dec; 25(6):466-9. PubMed ID: 22734238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of plasma exchange on entecavir-treated chronic hepatitis B patients with hepatic de-compensation and acute-on-chronic liver failure.
    Yue-Meng W; Yang LH; Yang JH; Xu Y; Yang J; Song GB
    Hepatol Int; 2016 May; 10(3):462-9. PubMed ID: 26482576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation in Hepatitis B Virus Related Acute-on-Chronic Liver Failure Treated with Plasma Exchange and Entecavir: a 24-Month Prospective Study.
    Li YH; Xu Y; Wu HM; Yang J; Yang LH; Yue-Meng W
    Stem Cell Rev Rep; 2016 Dec; 12(6):645-653. PubMed ID: 27687792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance.
    Lee S; Ahn SH; Jung KS; Kim DY; Kim BK; Kim SU; Baatarkhuu O; Ku HJ; Han K; Park JY
    J Viral Hepat; 2017 Feb; 24(2):141-147. PubMed ID: 27766731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.